Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations
NCT01988779
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Chronic Rhinosinusitis
Interventions
DRUG:
oral levofloxacin
DRUG:
nebulized levofloxacin
Sponsor
University of Rochester